Pharmalot... Pharmalittle... Good Morning

Good morning, everyone, and welcome to another working week. We hope the weekend was refreshing, because another busy few days are on the way. You know, that routine of meetings and deadlines and phone calls and running about has now begun. So please join us as we hoist a needed cup of stimulation in order to cope. And, of course, here are some tidbits to start the process. Have a great day and do stay in touch... Novo Nordisk To Invest $3.7 Billion On Diabetes Pill Portfolio (Reuters) Sanofi CEO Sees A Return To Growth In The Fourth Quarter (Bloomberg News) Ranbaxy Looks To Buy An FDA-Approved Plant In India (Economic Times) Ohio Turns To Compounding Pharmacies For Execution Drugs (Associated Press) Indian Drugmakers Increased R&D Spending By 20 Percent (PharmaBiz) HPV Vaccine Uptake Influenced By Culture And Lanugage: Study (MedPage Today) Novartis And Genentech's Xolair Shows Promise For Treating Hives (Pharma Times) Glenmark In Talks To Sell Oral Contraceptive Unit (Economic Times) EDITOR'S NOTE: Please check this post...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs